Elevate the Standard of Care for Women’s Health and STIs
Clinicians and laboratories are facing growing challenges in managing reproductive health and addressing patient needs. With rising healthcare costs due to an increasing number of new sexually transmitted infections (STIs), it’s essential to improve the testing and diagnosis of these infections. Traditional diagnostic methods for vaginal infections often leave up to 40% of women with vaginitis undiagnosed after the initial clinical visit, highlighting the need for advanced testing solutions.
Discover the BD MAX Women’s Health and STI Testing Portfolio
The BD MAX Women’s Health and STI portfolio offers accurate, reliable diagnostic solutions designed to help clinicians and labs improve patient care through better diagnostic capabilities.
- BD MAX Vaginal Panel for Accurate Vaginitis Diagnosis
Vulvovaginal complaints are one of the top reasons women seek medical care. The BD MAX Vaginal Panel offers comprehensive testing, ensuring accurate diagnosis and better treatment options.
- BD MAX CT/GC/TV for Comprehensive STI Testing
Simultaneously testing for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginalis (TV) is critical for the detection and treatment of the most common STIs in women. This comprehensive test enables more efficient and accurate results for female patients, addressing key health concerns.
- BD MAX GBS for Group B Streptococcus Detection
Group B streptococcal disease (GBS) is a leading cause of morbidity and mortality among newborns in the U.S. Early detection through BD MAX GBS testing helps reduce the risk of serious infections in infants.
References
- Centers for Disease Control and Prevention. http://www.cdc.gov/std/stats/sti-estimates-fact-sheet-feb-2013.pdf. Accessed September 19, 2016.
- Carr PL et al. “Shotgun” versus sequential testing. Cost-effectiveness of diagnostic strategies for vaginitis. JGIM. 2005;793-799.
- Hainer BL, Gibson MV. Vaginitis. Am Fam Physician. 2011;83(7):807-815.
- Baron EJ et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clin Infect Dis. 2013;57(4):e22-e121.
- Verani JR, McGee L, Schrag G; Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1-32.